Manning Anthony M.
SEC insider (Form 3/4/5 filer). CIK 0001716468. Director at Monte Rosa Therapeutics, Inc. (GLUE). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in BOSTON, MA.
Companies Manning Anthony M. has filed insider reports for
- Monte Rosa Therapeutics, Inc. (GLUE): Director
Manning Anthony M.
CIK: 0001716468
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Monte Rosa Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 11, 2026GLUE
Monte Rosa Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
25.8K shares- - May 21, 2026GLUE
Monte Rosa Therapeutics, Inc.
ExerciseDirect10K shares at avg. $4.16$42K - May 21, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect10K shares at avg. $18.01$180K - Jun 13, 2025GLUE
Monte Rosa Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
30.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Award Stock Option (Right to Buy) | 25,800 | - | - | Direct |
| May 21, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Exercise | 10,000 | $4.16 | $41,600 | Direct |
| May 21, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 10,000 | $18.01 | $180,100 | Direct |
| Jun 13, 2025 | GLUE Monte Rosa Therapeutics, Inc. | Award Stock Option (Right to Buy) | 30,700 | - | - | Direct |
1-4 of 4 transactions